Advanced Oncotherapy PLC represents a commitment to innovation, excellence, and patient-centric care in the field of advanced cancer treatment solutions. With a strong focus on delivering cutting-edge proton beam therapy technology, the company aims to revolutionize cancer treatment and enhance patient outcomes. Advanced Oncotherapy PLC is dedicated to providing personalized, precise, and cost-effective therapies to cancer patients worldwide. Its corporate philosophy revolves around advancing the field of oncology through research, collaboration, and continuous improvement. By harnessing state-of-the-art technology and prioritizing patient well-being, Advanced Oncotherapy PLC strives to make a meaningful difference in the fight against cancer.

Advanced Oncotherapy PLC is primarily present in the United Kingdom.

Advanced Oncotherapy PLC has achieved several significant milestones. One notable achievement is the successful completion of the first LIGHT system installation at a proton therapy center in Harley Street, London. Additionally, the company has made progress in securing partnerships and collaborations with recognized industry leaders. Advanced Oncotherapy PLC has also demonstrated its commitment to innovation by obtaining regulatory clearances and patents for its cutting-edge technologies. Furthermore, the company continues to advance its research and development efforts, aiming to provide effective and affordable cancer treatment solutions to patients worldwide.

Advanced Oncotherapy PLC is a leading company in the field of proton therapy technology. Established in 2006, the company is dedicated to advancing cancer treatment by developing and commercializing innovative proton therapy systems. Advanced Oncotherapy PLC aims to make proton therapy more accessible and affordable through its cutting-edge LIGHT system. This system leverages revolutionary technology, optimizing cancer treatment with precise doses of proton beams. The team behind Advanced Oncotherapy PLC consists of experienced professionals, including scientists and engineers, who are committed to making a significant impact on cancer care. With a strong focus on research and development, the company is poised to revolutionize cancer treatment worldwide.

The main competitors of Advanced Oncotherapy PLC in the market include Varian Medical Systems, Elekta AB, and Accuray Incorporated.

Advanced Oncotherapy PLC is primarily active in the healthcare industry. With a focus on innovative and advanced technologies, the company offers solutions for the treatment of cancer. Advanced Oncotherapy PLC develops and manufactures state-of-the-art proton therapy systems that aim to provide more precise and effective cancer treatments. By leveraging cutting-edge medical technology, the company strives to contribute to the advancement of cancer care and improve patient outcomes. With its presence in the healthcare sector, Advanced Oncotherapy PLC plays a significant role in addressing the critical needs of cancer patients and medical professionals.

The business model of Advanced Oncotherapy PLC focuses on developing and providing advanced technologies and innovative solutions for the treatment of cancer. The company specializes in the design, development, and commercialization of proton therapy systems, which enable precise and targeted radiation therapy. Advanced Oncotherapy PLC aims to revolutionize cancer treatment by offering cost-effective and compact proton beam therapy systems that are suitable for both large academic centers and private clinics. By harnessing the power of proton therapy, the company aims to improve patient outcomes while reducing the side effects typically associated with traditional radiation therapy methods.

Raportul Advanced Oncotherapy preț/beneficiu este -0,01.

Raportul Advanced Oncotherapy preț/vânzări este 0,00.

Scorul de calitate AlleAktien pentru Advanced Oncotherapy este 3/10.

Cifra de afaceri a așteptată Advanced Oncotherapy este de 103,31 milioane GBP.

Profitul așteptată Advanced Oncotherapy este -8,94 milioane GBP.

Advanced Oncotherapy is a medical company specializing in the development and manufacturing of advanced technologies for cancer treatment. Their business model includes technology development as well as providing services and products. The main product is the LIGHT (Linac Image Guided Hadron Technology) radiotherapy platform, which allows for precise targeted treatment of tumors in inaccessible areas of the body or near sensitive tissues using a combination of linear accelerator and hadron technology. They also offer services and products such as biopsy solutions and custom imaging solutions tailored to the specific needs of their customers. Additionally, they invest in research and development and collaborate with research institutions and universities. Their goal is to market and sell their technology globally by collaborating with distributors and governments to integrate their products into healthcare systems worldwide. Advanced Oncotherapy aims to continually innovate and provide better solutions for their customers, positioning them for future growth and success in the cancer treatment market.

Advanced Oncotherapy distribuie un dividend de 0 GBP în plăți anuale.

Dividenda nu poate fi calculată în prezent pentru Advanced Oncotherapy sau compania nu distribuie dividende.

Codul ISIN pentru Advanced Oncotherapy este GB00BD6SX109.

Codul WKN al Advanced Oncotherapy este A2AL9X.

Ticker-ul pentru Advanced Oncotherapy este AVO.L.

În ultimele 12 luni, Advanced Oncotherapy a plătit un dividend în valoare de . Aceasta corespunde unei randamente a dividendului de aproximativ . Pentru următoarele 12 luni, Advanced Oncotherapy va plăti probabil un dividend de 0 GBP.

Randamentul dividendelor pentru Advanced Oncotherapy este în prezent de .

Advanced Oncotherapy plătește un dividend trimestrial. Acesta este distribuit în lunile .

Advanced Oncotherapy a plătit dividende în fiecare an, în ultimii 0 ani.

Pentru următoarele 12 luni se așteaptă dividende în valoare de 0 GBP. Acest lucru corespunde unei randamente a dividendelor de 0 %.

Advanced Oncotherapy este atribuit sectorului 'Sănătate'.

Pentru a primi ultimul dividend de Advanced Oncotherapy de la 09.11.2024 în valoare de 0 GBP, trebuia să deții acțiunea în portofoliu înainte de ziua Ex-Tag de pe 09.11.2024.

Ultima plată a dividendului a fost efectuată la 09.11.2024.

În anul 2023, Advanced Oncotherapy a distribuit 0 GBP sub formă de dividende.

Dividendele de la Advanced Oncotherapy sunt distribuite în GBP.